Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan in First Episode Psychosis
NCT01720095Phase 3Completed
- Sponsor
- Nova Scotia Health
- Start
- Oct 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niacin in psychosis, sponsored by Nova Scotia Health. Started Oct 2009; status: completed.
02
Drugs
niacin
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT01720095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720095.